These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27847261)

  • 21. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: initial experiences in Japan.
    Kijima Y; Akagi T; Nakagawa K; Taniguchi M; Ueoka A; Deguchi K; Toh N; Oe H; Kusano K; Sano S; Ito H
    Cardiovasc Interv Ther; 2014 Jan; 29(1):11-7. PubMed ID: 23824518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter Closure of Patent Foramen Ovale: Devices and Technique.
    Price MJ
    Interv Cardiol Clin; 2017 Oct; 6(4):555-567. PubMed ID: 28886846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of inter-atrial communications (atrial septal defect and patent foramen ovale): single-centre experience and mid-term follow-up.
    Van de Bruaene A; Stroobants D; Benit E
    Acta Cardiol; 2015 Apr; 70(2):133-40. PubMed ID: 26148372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
    Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplatzer left atrial appendage occlusion through a patent foramen ovale.
    Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patent oval foramen transcatheter closure: results of a strategy based on tailoring the device to the specific patient's anatomy.
    Rigatelli G; Dell'Avvocata F; Ronco F; Giordan M; Cardaioli P
    Cardiol Young; 2010 Apr; 20(2):144-9. PubMed ID: 20219151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
    Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
    J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies.
    Geis NA; Pleger ST; Katus HA; Hardt SE
    J Interv Cardiol; 2015 Apr; 28(2):190-7. PubMed ID: 25728716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
    Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
    J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
    Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
    La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.
    Vitarelli A; Mangieri E; Capotosto L; Tanzilli G; D'Angeli I; Toni D; Azzano A; Ricci S; Placanica A; Rinaldi E; Mukred K; Placanica G; Ashurov R
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1377-85. PubMed ID: 25139906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up.
    Luani B; Markovic S; Krumsdorf U; Rottbauer W; Wöhrle J
    EuroIntervention; 2015 May; 11(1):85-91. PubMed ID: 25572024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up.
    Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ
    JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
    Siddiqui IF; Michaels AD
    J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.